Maximus, Inc. (NYSE:MMS) Insider Sells $787,258.92 in Stock

Maximus, Inc. (NYSE:MMS) insider Ilene R. Baylinson sold 9,681 shares of the company’s stock in a transaction on Friday, November 19th. The shares were sold at an average price of $81.32, for a total value of $787,258.92. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of MMS opened at $80.72 on Thursday. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.97. The business has a 50-day simple moving average of $84.17 and a two-hundred day simple moving average of $86.71. The stock has a market cap of $5.00 billion, a price-to-earnings ratio of 17.32 and a beta of 0.76. Maximus, Inc. has a 52 week low of $67.65 and a 52 week high of $96.05.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, November 18th. The health services provider reported $1.08 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.21. Maximus had a return on equity of 22.53% and a net margin of 6.84%. The business had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.08 billion. During the same quarter in the prior year, the business posted $1.02 earnings per share. The business’s quarterly revenue was up 19.7% on a year-over-year basis. On average, equities analysts anticipate that Maximus, Inc. will post 4.15 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 30th. Investors of record on Monday, November 15th will be given a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend is Friday, November 12th. Maximus’s dividend payout ratio is currently 24.03%.

Several large investors have recently added to or reduced their stakes in the stock. Coyle Financial Counsel LLC grew its position in shares of Maximus by 35.8% during the third quarter. Coyle Financial Counsel LLC now owns 22,831 shares of the health services provider’s stock worth $1,900,000 after purchasing an additional 6,015 shares in the last quarter. Bank of New York Mellon Corp grew its position in shares of Maximus by 3.0% during the third quarter. Bank of New York Mellon Corp now owns 1,094,446 shares of the health services provider’s stock worth $91,058,000 after purchasing an additional 31,970 shares in the last quarter. Personal CFO Solutions LLC grew its position in shares of Maximus by 6.3% during the third quarter. Personal CFO Solutions LLC now owns 3,151 shares of the health services provider’s stock worth $262,000 after purchasing an additional 186 shares in the last quarter. Gyon Technologies Capital Management LP grew its position in shares of Maximus by 27.4% during the third quarter. Gyon Technologies Capital Management LP now owns 3,266 shares of the health services provider’s stock worth $272,000 after purchasing an additional 703 shares in the last quarter. Finally, Cetera Investment Advisers grew its position in shares of Maximus by 6.9% during the third quarter. Cetera Investment Advisers now owns 4,034 shares of the health services provider’s stock worth $336,000 after purchasing an additional 261 shares in the last quarter. Hedge funds and other institutional investors own 94.30% of the company’s stock.

Separately, Zacks Investment Research cut Maximus from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a research report on Tuesday.

Maximus Company Profile

MAXIMUS, Inc engages in the operation of government and human services programs. It operates through the following segments: U.S. Services; U.S. Federal Services; and Outside the U.S. The U.S. Services segment offers a variety of business process services, and appeals and assessments for state, provincial and national government programs.

Further Reading: Understanding each part of a balance sheet

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.